Quarterly report pursuant to Section 13 or 15(d)

Summary of Dilutive Common Shares were Excluded from Calculation of Diluted Net Loss Per Share (Details)

v3.22.2.2
Summary of Dilutive Common Shares were Excluded from Calculation of Diluted Net Loss Per Share (Details) - shares
 3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Total 753,905 283,521 753,905 283,521
Shares Subject To Options To Purchase Common Stock [Member]        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Total 62,548 106,644 62,548 106,644
Unvested Restricted Stock Units [Member]        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Total 691,355 176,877 691,355 176,877
Shares Subject To Warrants To Purchase Common Stock [Member]        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Total 2 2